Prophetic Medicine-Nigella Sativa (Black cumin seeds) - Potential herb for COVID-19?
Anti-inflammatory
Anticoagulant
Antioxidant
Antiviral
Black seeds
Nigella sativa
Journal
Journal of pharmacopuncture
ISSN: 2093-6966
Titre abrégé: J Pharmacopuncture
Pays: Korea (South)
ID NLM: 101572812
Informations de publication
Date de publication:
30 Jun 2020
30 Jun 2020
Historique:
received:
30
05
2020
revised:
02
06
2020
accepted:
08
06
2020
entrez:
21
7
2020
pubmed:
21
7
2020
medline:
21
7
2020
Statut:
ppublish
Résumé
Coronavirus disease-19 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). Currently, the management of patients with COVID-19 depends mainly on repurposed drugs which include chloroquine, hydroxychloroquine, lopinavir/ritonavir, ribavirin, remdesivir, favipiravir, umifenovir, interferon-α, interferon-β and others. In this review, the potential of Nigella sativa (black cumin seeds) to treat the patients with COVID-19 analyzed, as it has shown to possess antiviral, antioxidant, anti-inflammatory, anticoagulant, immunomodulatory, bronchodilatory, antihistaminic, antitussive, antipyretic and analgesic activities. PubMed, Google Scholar, Science Direct, Directory of open access journals (DOAJ) and reference lists were searched to identify articles associated with antiviral and other properties of N.sativa related to the signs and symptoms of COVID-19. Various randomized controlled trials, pilot studies, case reports and in vitro and in vivo studies confirmed that N.sativa has antiviral, antioxidant, anti-inflammatory, immunomodulatory, bronchodilatory, antihistaminic, antitussive activities related to causative oraganism and signs and symptoms of COVID-19.
Identifiants
pubmed: 32685234
doi: 10.3831/KPI.2020.23.010
pii: 2093-6966-v23-n02-062
pmc: PMC7338708
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
62-70Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2020 Korean Pharmacopuncture Institute.
Déclaration de conflit d'intérêts
Conflict of Interest The authors declare that there are no conflicts of interest.
Références
Afr J Tradit Complement Altern Med. 2016 Sep 29;13(6):144-148
pubmed: 28480371
Antioxidants (Basel). 2019 Feb 25;8(2):
pubmed: 30823525
World J Gastroenterol. 2013 Apr 28;19(16):2529-36
pubmed: 23674855
J Pharmacopuncture. 2017 Sep;20(3):158-172
pubmed: 30087792
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
Med Princ Pract. 2010;19(3):206-11
pubmed: 20357504
Inflammopharmacology. 2016 Jun;24(2-3):67-79
pubmed: 27068721
J Cell Biochem. 2019 Mar;120(3):4514-4522
pubmed: 30269355
Phytother Res. 2000 Aug;14(5):323-8
pubmed: 10925395
Int Immunopharmacol. 2005 Dec;5(13-14):1749-70
pubmed: 16275613
Avicenna J Phytomed. 2016 Jan-Feb;6(1):34-43
pubmed: 27247920
Int J Immunopharmacol. 2000 Sep;22(9):729-40
pubmed: 10884593
Am J Otolaryngol. 2011 Sep-Oct;32(5):402-7
pubmed: 20947211
Int J Health Sci (Qassim). 2019 Jan-Feb;13(1):1-2
pubmed: 30842710
Can Geriatr J. 2020 Mar 01;23(1):149-151
pubmed: 32269670
Oncotarget. 2017 Dec 14;9(6):7204-7218
pubmed: 29467962
Phytomedicine. 2010 Aug;17(10):707-13
pubmed: 20149611
Afr J Tradit Complement Altern Med. 2013 Aug 12;10(5):332-5
pubmed: 24311845
SAGE Open Med. 2013 Dec 24;1:2050312113517501
pubmed: 26770698
Arch Med Res. 2020 Jul;51(5):384-387
pubmed: 32402576
J Enzyme Inhib Med Chem. 2004 Oct;19(5):431-6
pubmed: 15648658
Afr J Tradit Complement Altern Med. 2011;8(1):37-44
pubmed: 22238482
Chin J Nat Med. 2016 Oct;14(10):732-745
pubmed: 28236403
Antiinflamm Antiallergy Agents Med Chem. 2014 Mar;13(1):75-82
pubmed: 23855426
Br J Haematol. 2020 Jun;189(6):1060-1061
pubmed: 32400024
Avicenna J Phytomed. 2020 Mar-Apr;10(2):181-189
pubmed: 32257890
Int J Mol Sci. 2016 Mar 30;17(4):474
pubmed: 27043539
Phytother Res. 2012 Aug;26(8):1246-8
pubmed: 22162258
Phytother Res. 2015 Nov;29(11):1722-8
pubmed: 26179113
Respir Med Case Rep. 2020 Apr 21;:101063
pubmed: 32322478
Nat Rev Immunol. 2020 Jun;20(6):355-362
pubmed: 32376901
EXCLI J. 2013 Nov 11;12:943-55
pubmed: 27298610
Lancet Infect Dis. 2020 Apr;20(4):400-402
pubmed: 32113509
J Clin Lipidol. 2016 Sep-Oct;10(5):1203-11
pubmed: 27678438
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Immunol Invest. 2016 May;45(4):271-83
pubmed: 27100726
Lancet Respir Med. 2020 Jun;8(6):544-546
pubmed: 32380023
Lancet Respir Med. 2020 Jun;8(6):e46-e47
pubmed: 32353251
Asian Pac J Trop Biomed. 2013 May;3(5):337-52
pubmed: 23646296
Saudi Med J. 2016 Mar;37(3):235-44
pubmed: 26905343
Int J Cardiol. 2020 Aug 1;312:137-138
pubmed: 32321655
JAMA. 2020 Apr 13;:
pubmed: 32282022
J Ethnopharmacol. 2016 Aug 22;190:372-86
pubmed: 27364039
PLoS One. 2015 Feb 23;10(2):e0113486
pubmed: 25706772
Ann Saudi Med. 2017 Jan-Feb;37(1):64-71
pubmed: 28151459